Search clinical trials for: Adrenergic beta-Agonists
Total 18658 results
-
Henning BundgaardCompletedChronic Heart Failure With Reduced Ejection Fraction (HFrEF)Australia, Denmark
-
Aaron CypessNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...Completed
-
Yonsei UniversityActive, not recruitingPatients With Low Bladder Compliance of 20ml/H2O or Less Despite Taking AnticholinergicsKorea, Republic of
-
University Hospital, Basel, SwitzerlandCompletedThermogenesisSwitzerland
-
GlaxoSmithKlineCompletedOveractive BladderUnited States
-
GlaxoSmithKlineCompletedOveractive BladderGermany, Taiwan, Netherlands, Spain, Australia, Korea, Republic of, Latvia, Argentina, Slovenia, Finland, France, South Africa, Poland, New Zealand
-
GlaxoSmithKlineCompletedIrritable Bowel Syndrome (IBS)Germany, Australia, France
-
Zhejiang Provincial People's HospitalRecruiting
-
Southern Illinois UniversityAstellas Scientific & Medical Affairs, Inc.; Sisters of the Third Order of...CompletedLower Urinary Tract Symptoms | NocturiaUnited States
-
Peking Union Medical College HospitalNot yet recruiting
-
CHU de Quebec-Universite LavalCompletedOveractive Bladder | Urinary Incontinence
-
Johns Hopkins UniversityAstellas Pharma US, Inc.CompletedOveractive Bladder | Urinary Incontinence | Erectile DysfunctionUnited States
-
State University of New York at BuffaloAstellas Pharma IncWithdrawnUrinary Frequency/Urgency | Bladder Pain Syndrome | Bladder IrritableUnited States
-
Mansoura UniversityUnknownProstatic Neoplasms | Erectile Dysfunction | BPH | Prostate Hyperplasia | Erectile AbnormalitiesEgypt
-
Fundación Centro Nacional de Investigaciones Cardiovasculares...Hospital Clinic of Barcelona; Fundació Institut de Recerca de l'Hospital de... and other collaboratorsUnknownHeart Failure | Pulmonary Hypertension | Mirabegron | Pulmonary Vascular Resistance Abnormality
-
Karolinska InstitutetCompletedOveractive BladderSweden
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of MirabegronFrance
-
Astellas Pharma China, Inc.CompletedHealthy Chinese VolunteersChina
-
Mansoura UniversityNot yet recruitingOveractive Bladder | Voiding Disorders
-
Taipei Veterans General Hospital, TaiwanRecruitingOveractive Bladder SyndromeTaiwan
-
Southern Illinois UniversityAstellas Scientific & Medical Affairs, Inc.; Sisters of the Third Order of...TerminatedPain | Urinary Bladder, Overactive | Lower Urinary Tract SymptomsUnited States
-
University of FloridaNational Institute of General Medical Sciences (NIGMS)TerminatedPulmonary Hypertension | Heart Failure With Preserved Ejection Fraction | Diastolic Heart FailureUnited States
-
The University of Texas Health Science Center at...CompletedCognitive Change | Spinal Cord Injuries | Neurogenic BladderUnited States
-
Loyola UniversityAstellas Pharma US, Inc.Completed
-
Buddhist Tzu Chi General HospitalUnknownOveractive Bladder SyndromeTaiwan
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveJapan
-
Astellas Pharma IncCompletedOveractive Bladder | Cardiovascular DiseaseJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedIntraocular PressureUnited States
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | Mild and Moderate Hepatic ImpairmentSlovakia
-
GlaxoSmithKlineCompletedIrritable Bowel Syndrome (IBS)United States
-
Mylan Bertek PharmaceuticalsCompletedHypertensionUnited States
-
Oregon Health and Science UniversityCompletedObesity | Cardiovascular Risk Factor | Circadian DysregulationUnited States
-
Indiana UniversityOffice of Naval Research (ONR)RecruitingResting Energy Expenditure | Brown Adipose Tissue | ThermogenesisUnited States
-
Indiana UniversityOffice of Naval Research (ONR)CompletedResting Energy Expenditure | Brown Adipose Tissue | ThermogenesisUnited States
-
Korea University Anam HospitalActive, not recruitingHypertensionKorea, Republic of
-
Astellas Pharma China, Inc.CompletedPharmacokinetics of Mirabegron | Food Effect | Healthy Chinese SubjectsChina
-
Swiss Group for Clinical Cancer ResearchCompletedPrimary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Myeloproliferative NeoplasmSwitzerland
-
CHU de Quebec-Universite LavalCompletedOveractive Bladder | Urinary Incontinence
-
Mercy ResearchForest LaboratoriesCompletedHypertensionUnited States
-
Astellas Pharma IncCompleted
-
Mylan Bertek PharmaceuticalsCompleted
-
Henning BundgaardHvidovre University Hospital; Herlev Hospital; Royal North Shore Hospital; Bispebjerg-Frederiksberg... and other collaboratorsCompletedHeart Failure With Reduced Ejection Fraction NYHA Class III-IVDenmark
-
Far Eastern Memorial HospitalWithdrawnOveractive Bladder SyndromeTaiwan
-
GlaxoSmithKlineCompleted
-
Seoul National University HospitalUnknown
-
AstraZenecaCompleted
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive BladderPoland, United Kingdom, Germany, Spain, Netherlands, Belgium, Czech Republic, Italy, Norway, Hungary, Sweden, Denmark, Greece, France, Russian Federation
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of MirabegronUnited States
-
Mylan Bertek PharmaceuticalsCompleted